Triclosan-antibacterial Sutures Impact on the Incidence of Surgical Site Infection in Laparoscopic Surgeries.

ClinAmygate

Status and phase

Completed

Phase 4

Conditions

Laparoscopic Surgery

Surgical Site Infection

Surgical Wound

Treatments

Drug: Coated Vicryl plus

Drug: Coated vicryl

Study type

Interventional

Funder types

Other

Identifiers

NCT04255927

PR2019-26

Details and patient eligibility

About

Comparing the incidence of PSI in cases using coated Polyglactin 910 suture with Triclosan and cases using Polyglactin 910 suture without Triclosan in laparoscopic sleeve gastrectomy, laparoscopic appendectomy or laparoscopic cholecystectomy.

Full description

In this prospective study, we will determine the incidence of PSI in Egypt as well as the impact of using coated polyglactin 910 sutures with Triclosan in lowering the incidence of PSI in laparoscopic sleeve gastrectomy, laparoscopic appendectomy or laparoscopic cholecystectomy.

Enrollment

912 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

age 18-75
candidate for laparoscopic surgical intervention during the period of the study were included.

Exclusion criteria

Patient has immunodeficiency disorder.
Patient receiving anti-cancer / immunosuppressive therapy.
Patients with established pre-operative infection whether community acquired or hospital acquired either at / remote from the operative site.